WILSON MARK ANDREW (SVP & General Counsel) sold 2.8% of their position (630.00 shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $34.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/25/2025ACC: 0001193125-25-297852
Officer· SVP & General Counsel
Since Mar 2020
+4.67K
Net shares
Net buyer
$34.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.30K acquired · 630.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.90K
Price / share
—
Trade value
—
% of position
9.4%
11/21/2025
20.31K→22.21K
Common Stock
Direct
Shares
−630.00
Price / share
$54.28
Trade value
$34.20K
% of position
2.8%
11/25/2025
22.21K→21.59K
Total
Net shares
+1.27K
Net value
-$34.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | A · Award | +1.90K | — | — | 9.4% | 20.31K | 22.21K |
| Common Stock Direct | 11/25/2025 | S · Sale | −630.00 | $54.28 | $34.20K | 2.8% | 22.21K | 21.59K |
| Total | +1.27K | -$34.20K | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
3.40K shares
Shares
+3.40K
Strike price
281.25
Held after
3.40K
Exercisable
—
11/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock3.40K shares | 11/21/2025 | A · Award | +3.40K | 281.25 | — | 3.40K |